162 related articles for article (PubMed ID: 28432514)
1. Breast cancer treatment costs in younger, privately insured women.
Allaire BT; Ekwueme DU; Poehler D; Thomas CC; Guy GP; Subramanian S; Trogdon JG
Breast Cancer Res Treat; 2017 Jul; 164(2):429-436. PubMed ID: 28432514
[TBL] [Abstract][Full Text] [Related]
2. Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.
Trogdon JG; Ekwueme DU; Poehler D; Thomas CC; Reeder-Hayes K; Allaire BT
Breast Cancer Res Treat; 2017 Nov; 166(1):207-215. PubMed ID: 28702893
[TBL] [Abstract][Full Text] [Related]
3. Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years.
Allaire BT; Ekwueme DU; Guy GP; Li C; Tangka FK; Trivers KF; Sabatino SA; Rodriguez JL; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):270-7. PubMed ID: 26775906
[TBL] [Abstract][Full Text] [Related]
4. Medical costs associated with metastatic breast cancer in younger, midlife, and older women.
Trogdon JG; Baggett CD; Gogate A; Reeder-Hayes KE; Rotter J; Zhou X; Ekwueme DU; Fairley TL; Wheeler SB
Breast Cancer Res Treat; 2020 Jun; 181(3):653-665. PubMed ID: 32346820
[TBL] [Abstract][Full Text] [Related]
5. Estimation of Breast Cancer Incident Cases and Medical Care Costs Attributable to Alcohol Consumption Among Insured Women Aged <45 Years in the U.S.
Ekwueme DU; Allaire BT; Parish WJ; Thomas CC; Poehler D; Guy GP; Aldridge AP; Lahoti SR; Fairley TL; Trogdon JG
Am J Prev Med; 2017 Sep; 53(3S1):S47-S54. PubMed ID: 28818245
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.
Epstein AJ; Wong YN; Mitra N; Vachani A; Hin S; Yang L; Smith-McLallen A; Armstrong K; Groeneveld PW
J Clin Oncol; 2015 Dec; 33(36):4259-67. PubMed ID: 26598749
[TBL] [Abstract][Full Text] [Related]
7. The relation between health insurance coverage and clinical outcomes among women with breast cancer.
Ayanian JZ; Kohler BA; Abe T; Epstein AM
N Engl J Med; 1993 Jul; 329(5):326-31. PubMed ID: 8321261
[TBL] [Abstract][Full Text] [Related]
8. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
Fu AZ; Jhaveri M
J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589
[TBL] [Abstract][Full Text] [Related]
9. Productivity Costs Associated With Breast Cancer Among Survivors Aged 18-44 Years.
Ekwueme DU; Trogdon JG; Khavjou OA; Guy GP
Am J Prev Med; 2016 Feb; 50(2):286-94. PubMed ID: 26775908
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.
Khanna R; Madhavan SS; Bhanegaonkar A; Remick SC
J Womens Health (Larchmt); 2011 May; 20(5):739-47. PubMed ID: 21417935
[TBL] [Abstract][Full Text] [Related]
12. Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.
Ekwueme DU; Allaire BT; Guy GP; Arnold S; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):278-85. PubMed ID: 26775907
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
14. The financial burden of cancer: estimates from a study of insured women with breast cancer.
Arozullah AM; Calhoun EA; Wolf M; Finley DK; Fitzner KA; Heckinger EA; Gorby NS; Schumock GT; Bennett CL
J Support Oncol; 2004; 2(3):271-8. PubMed ID: 15328826
[TBL] [Abstract][Full Text] [Related]
15. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.
Baser O; Wei W; Henk HJ; Teitelbaum A; Xie L
Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568
[TBL] [Abstract][Full Text] [Related]
16. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care.
Taplin SH; Barlow W; Urban N; Mandelson MT; Timlin DJ; Ichikawa L; Nefcy P
J Natl Cancer Inst; 1995 Mar; 87(6):417-26. PubMed ID: 7861461
[TBL] [Abstract][Full Text] [Related]
17. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.
Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160
[TBL] [Abstract][Full Text] [Related]
18. Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population.
Ray S; Bonthapally V; McMorrow D; Bonafede M; Landsman-Blumberg P
J Comp Eff Res; 2013 Mar; 2(2):195-206. PubMed ID: 24236561
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of health care costs for bone fractures in women with early-stage breast carcinoma.
Zhou Z; Redaelli A; Johnell O; Willke RJ; Massimini G
Cancer; 2004 Feb; 100(3):507-17. PubMed ID: 14745866
[TBL] [Abstract][Full Text] [Related]
20. Cost of breast cancer based on real-world data: a cancer registry study in Italy.
Capri S; Russo A
BMC Health Serv Res; 2017 Jan; 17(1):84. PubMed ID: 28122558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
